关于控股股东、实际控制人兼董事长及其一致行动人权益变动触及1%整数倍的提示性公告
Filed with SSE ·
On 6ix: 6ix.com/news/1percent
6ix hasn’t read this filing yet.
Shenzhen YHLO Biotech Co. Ltd. on 6ix
Earlier from Shenzhen YHLO Biotech
- Announcement on Selection of the Manufacturing Industry Single Crown Enterprises
- Announcement on the Achievements of Vesting Conditions in the 2nd Vesting Period of the 2023 Restricted Stock Incentive Plan
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Voluntary Disclosure of Receipt of Notification for Grant of Invention Patent Rights
- Announcement on Voluntary Disclosure of Obtaining IVDR CE Certificate
Later from Shenzhen YHLO Biotech
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Vesting Results in the 2nd Vesting Period of the 2023 Restricted Stock Incentive Plan (1st Batch) and Shares Listing
- Announcement on the Change in the Shareholding of the Controlling Shareholder, Actual Controller and Chairman and Persons Acting in Concert reaching an Integral Multiple of 1%, and the Results of Shareholding Reduction by the Chairman, and Partial Senior Management Members and Key Technical Personnel
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
Follow Shenzhen YHLO Biotech into a list and get an email when it puts out news.
Follow Shenzhen YHLO Biotech